gallic acid has been researched along with Cardiovascular Diseases in 6 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation." | 5.72 | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice. ( An, X; Bai, J; Liao, J; Lin, QY; Liu, S; Wang, Y; Xie, Y, 2022) |
| "Oxidative imbalance plays a key role in cancer induction and cardiovascular diseases (CVD) in patients with type 2 diabetes mellitus (T2DM)." | 2.87 | Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study. ( Al-Serori, H; Brath, H; Ferk, F; Knasmueller, S; Kundi, M; Marculescu, R; Mišík, M; Saiko, P; Szekeres, T; Wagner, KH, 2018) |
| "Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation." | 1.72 | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice. ( An, X; Bai, J; Liao, J; Lin, QY; Liu, S; Wang, Y; Xie, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, J | 1 |
| Lin, QY | 1 |
| An, X | 1 |
| Liu, S | 1 |
| Wang, Y | 1 |
| Xie, Y | 1 |
| Liao, J | 1 |
| Ferk, F | 1 |
| Kundi, M | 1 |
| Brath, H | 1 |
| Szekeres, T | 1 |
| Al-Serori, H | 1 |
| Mišík, M | 1 |
| Saiko, P | 1 |
| Marculescu, R | 1 |
| Wagner, KH | 1 |
| Knasmueller, S | 1 |
| Bondia-Pons, I | 1 |
| Pöhö, P | 1 |
| Bozzetto, L | 1 |
| Vetrani, C | 1 |
| Patti, L | 1 |
| Aura, AM | 1 |
| Annuzzi, G | 1 |
| Hyötyläinen, T | 1 |
| Rivellese, AA | 1 |
| Orešič, M | 1 |
| Kang, N | 1 |
| Lee, JH | 1 |
| Lee, W | 1 |
| Ko, JY | 1 |
| Kim, EA | 1 |
| Kim, JS | 1 |
| Heu, MS | 1 |
| Kim, GH | 1 |
| Jeon, YJ | 1 |
| Liu, XH | 1 |
| Pan, LL | 1 |
| Zhu, YZ | 1 |
| Wartanowicz, M | 1 |
2 reviews available for gallic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Active chemical compounds of traditional Chinese medicine Herba Leonuri: implications for cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Drugs, Chinese Herbal; Flavonoids; Gallic Acid; Humans; Leonurus; | 2012 |
[The influence of carotenoids and synthetic beta-carotene on human health].
Topics: beta Carotene; Cardiovascular Diseases; Carotenoids; Dietary Supplements; Gallic Acid; Humans; Macul | 2001 |
2 trials available for gallic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus, Type 2; DN | 2018 |
Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk.
Topics: Adult; Aged; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Diet; Fatty Acids, Omega-3; | 2014 |
2 other studies available for gallic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Diseases; Diet, High-Fat; Gallic Acid; I | 2022 |
Gallic acid isolated from Spirogyra sp. improves cardiovascular disease through a vasorelaxant and antihypertensive effect.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Cardiovasc | 2015 |